
The latest thought leadership from our expert teams

Our core technology is at the heart of the world’s first FDA-approved fully at-home COVID-19 test
The rapid, at home COVID-19 antigen test from digital diagnostics company Ellume features core technology from Cambridge Consultants. Read how this FDA approved test is set to be a game-changer in the global pandemic.
- Bioinnovation
- Digital health
- Fluids & thermodynamics
- Sensing

Engineering the future of innovations in oncology
This paper highlights macro and micro factors affecting oncology and proposes a partnership-driven framework to catalyze innovation for oncology-focused biopharma – as well as the role that select high-impact technologies will have on the on the entire value-chain of cancer research and care delivery.
- AI & Analytics
- Bioinnovation
- Digital health
- Dispense
- Robotics
- Sensing

Building the business of biodesign
Synthetic biology remains nascent, yet full of promise. The idea of using rational engineering approaches to design biology has the potential to solve some of humanity’s biggest challenges, such as securing food supplies...
- Bioinnovation
- Innovation management
- Product realisation
- Strategic advice

UK Human Tissue Authority licence enhances our next-generation therapy development
We are delighted to report a significant step forward as we grow our bioinnovation capability as we have received our licence from the UK Human Tissue Authority to store human tissue for research purposes. This opens the way to future development in cell therapies and regenerative medicine.
- Bioinnovation

Mixing it up – a possible way to provide COVID-19 testing for all
Symon Cotton explores the use of pooled testing techniques for deploying mass Covid testing.
- Bioinnovation

Food, sustainability and COVID drive a sense of urgency at SynBioBeta 2020
James Hallinan's takeaway from SynBioBeta 2020: Synbio is growing up and getting ever more relevant to the everyday.
- Bioinnovation

No more walking on eggshells: is the way we make vaccines changing forever?
With a constant stream of good news about potential COVID-19 vaccines, we reflect on traditional viral vaccine manufacturing processes and how we apply what we’re learning during this pandemic to legacy techniques.
- Bioinnovation

Bioinnovation: from research to commercialisation
The UK biotechnology scene is buzzing with debate right now, with critical themes like green growth and sustainability really coming to the fore. The pandemic has thrust science and scientists into the spotlight like never before – and each of us has a responsibility to contribute to the sort of response that will help create a more resilient world.
- Bioinnovation
- Project management
- Strategic advice

Bioinnovation - joining cool science to global issues via business reality
Richard Hammond presents a seminar on Bioinnovation from Innovation Day UK 2019.
- Bioinnovation

Synthetic biology: plotting a route from start-up to commercial value
One of the advantages of my role here at Cambridge Consultants is getting to swap thoughts and opinions with some of the brightest minds in the bioeconomy. Collaborating with members of the SynBioBeta network...
- Bioinnovation
- Innovation management
- Strategic advice

Bioinnovation - more than just technology
Richard Hammond, Head of Synthetic Biology, discusses the advances being made in bioinnovation.
- Bioinnovation
PHA: plastic the way nature intended?
Our whitepaper looks at the potential of PHA bioplastics in the food service industry. We've designed a range of sustainable, biodegradable plastic products, all served up on a bioplastic tray...
- Bioinnovation
- Industrial design
- Innovation management
- Product realisation